Renaissance Technologies - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 44 filers reported holding VINCERX PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q3 2023$134
-35.3%
132,900
-16.5%
0.00%
Q2 2023$207
+2.0%
159,100
-18.4%
0.00%
Q1 2023$203
+9.7%
195,000
+7.7%
0.00%
Q4 2022$185
-100.0%
181,000
-41.4%
0.00%
-100.0%
Q3 2022$426,000
+3.1%
308,700
-1.2%
0.00%
Q2 2022$413,000
-27.2%
312,522
+120.5%
0.00%
-100.0%
Q1 2022$567,000
+14.5%
141,744
+363.2%
0.00%0.0%
Q3 2021$495,000
-44.9%
30,600
-55.7%
0.00%0.0%
Q2 2021$898,00069,1000.00%
Other shareholders
VINCERX PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,658,199$2,189,0000.84%
Affinity Asset Advisors, LLC 1,374,098$1,814,0000.76%
SABBY MANAGEMENT, LLC 500,559$661,0000.45%
TANG CAPITAL MANAGEMENT LLC 1,030,634$1,360,0000.21%
Rubric Capital Management LP 2,107,000$2,781,0000.15%
Long Focus Capital Management, LLC 980,000$1,294,0000.14%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$508,0000.09%
Clearline Capital LP 452,184$597,0000.08%
Sio Capital Management, LLC 102,049$135,0000.05%
Rock Springs Capital Management LP 814,194$1,075,0000.03%
View complete list of VINCERX PHARMA INC shareholders